Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs

The Activate study

Dados Bibliográficos

ID14906182
AutoresHåvard Midgard (0000-0001-5043-5107, Oslo University Hospital, autor correspondente), Behzad Hajarizadeh (0000-0003-2212-2028, UNSW Sydney), Evan B Cunningham (0000-0002-8048-3473, UNSW Sydney), Brian Conway (0000-0001-6821-7829, Vancouver Infectious Diseases Centre), Markus Backmund (Ludwig-Maximilians-Universität München), Philip Bruggmann (0000-0002-0436-8895, Addiction Switzerland), Julie Bruneau (0000-0002-3484-6456, Université de Montréal), Stefan Bourgeois (Ziekenhuisnetwerk Antwerpen Stuivenberg), Adrian J Dunlop (0000-0003-2394-5966, University of Newcastle Australia), Adrian Dunlop, Graham R Foster (0000-0002-3704-386X, Queen Mary University of London), Margaret Hellard (0000-0002-5055-3266, Burnet Institute), Geert Robaeys (Universitair Ziekenhuis Leuven), Maria Christine Thurnheer (0000-0003-1357-0347, University of Bern), Michelle Weltman (0000-0002-1677-7653, Nepean Hospital), Martin Weltman, Janaki Amin (0000-0003-2161-9366, UNSW Sydney), Philippa S Marks, Philippa Marks (0000-0003-0480-1203, UNSW Sydney), Sophie Quiene (UNSW Sydney), Gregory J Dore (0000-0002-4741-2622, UNSW Sydney), Olav Dalgard (0000-0003-4470-3181, University of Oslo), J Grebely (0000-0002-1833-2017, UNSW Sydney)
Ano2017
Volume47
Páginas230-238
Data de publicação2017-09-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoInternational Journal of Drug Policy (JOURNAL)
Identificadores do periódicoISSN: 0955-3959 • E-ISSN: 1873-4758
EditoraElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2017.05.040
PMID28633998
OpenAlexW2626049294
IdiomaEN
Citações recebidas7
Referências citadas32